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Abstract: The effects of motor imagery (MI) on functional recovery of patients with neurological
pathologies, such as stroke, has been recently proven. The aim of this study is to evaluate the
effectiveness of MI on motor recovery and quality of life (QOL) in patients with multiple sclerosis
(pwMS). A search was carried out in the following scientific databases: PubMed, CINAHL, PEDro,
Scopus, Cochrane and Web of Science, up to November 2020. The grey literature and reference lists
of potentially relevant articles were also searched. The Checklist for Measuring Quality and The
Cochrane collaboration’s tool were used to assess the methodological quality and risk of bias of the
studies. Five studies were included in the systematic review. Findings showed that pwMS using MI
had significant improvements in walking speed and distance, fatigue and QOL. In addition, several
benefits were also found in dynamic balance and perceived walking ability. Although the evidence
is limited, rehabilitation using MI with the application of musical and verbal guides (compared to
non-intervention or other interventions), can produce benefits on gait, fatigue and QOL in pwMS
with a low score in the Expanded Disability Status Scale.
Keywords: motor imagery; mental processes; psychomotor performance; rehabilitation; multiple
sclerosis
1. Introduction
Multiple sclerosis is a demyelinating, chronic and autoimmune neurological pathol-
ogy. Morphologically, it presents with inflammation, demyelination and axonal damage,
which affects the entire central nervous system, causing very varied symptoms [1]; thus, it
represents the most common chronic neurological disease in young adults [2]. The quality
of life (QOL) and functional outcomes of patients with multiple sclerosis (pwMS), such
as mobility, aerobic performance and muscle strength, can be improved through the im-
plementation of structured and multidisciplinary rehabilitation programmes and physical
therapy [3]. In addition to conventional physical therapy, there are many interventions
focused on complement these programmes [4]. Some methods, such as virtual reality, count
with already proven evidence in pwMS [5]. In this way, the applicability of motor imagery
(MI) techniques has recently been shown in different rehabilitation contexts [6]. MI is
defined as a mental practice of movements without actually executing them. Parts of the
cortical networks involved in motor control that are activated during actual movement are
also activated during MI [7]. MI is widely used for the study of cognitive aspects of action
control and can be applied in various motor training and (re)learning environments, both
in the healthy population and clinical conditions [8,9]. In 1964, Richardson first discussed
the possibility of using mental practise through MI as a practical technique for physical
therapists in the motor rehabilitation process [10].
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Recently, several review articles analysed MI interventions in various neurological
disorders (stroke, Parkinson’s disease, spinal cord injury and amputation), underscoring
the positive effects of mental training on motor performance [11–13] and highlighting
changes in motor impairment favoured by MI [14,15]. Specifically, promising findings
were reported on gait and fatigue improvement in pwMS [16]. Although some reviews
provided relevant information on this topic [17], some of them did not specifically focus
on pwMS or did not exclusively consider MI as a form of intervention [18]. Moreover,
no systematic review has been reported on MI effectiveness in pwMS that specifically
focused on functional and motor recovery. Relevant here, it would be of interest take into
account the effects produced by other forms of mental practice on variables as important
as pain [19]. Recent studies support the interest of clinicians in obtaining evidence on the
effectiveness of this technique [20,21] as well as in knowing the most important parameters
that optimise its application. Considering the extensive data available on MI as a treatment
option in neurological disorders other than multiple sclerosis [13,22,23], it is important to
gather data on MI as a tool to be used by physical therapists dealing with pwMS. For this
reason, the main objective of this systematic review was to analyse the effectiveness of the
MI technique in the rehabilitation of pwMS, first obtaining a general view of literature on
this issue, then summarising benefits and limitations of MI, and finally evaluating and
comparing the most studied variables (gait, balance, fatigue and QOL) relevant to the
effectiveness of MI in treatment of pwMS.
2. Materials and Methods
This study followed the scheme of a systematic review concerning the Preferred
Reporting Items for Systematic Review and Meta-Analysis (PRISMA) model [24].
2.1. Search Strategy
An exhaustive search was performed up to November 2020 in the most common
scientific databases: Medline/PubMed, Scopus, Cochrane Plus, CINAHL, Web of Science
and PEDro. In addition, a Google Scholar database search was conducted to find ‘grey’
literature and the reference lists of retrieved papers were examined to identify further
relevant studies. The following descriptors obtained from MeSH were used to build the
search query: “multiple sclerosis”, “rehabilitation”. Other free terms, “motor imagery”,
“mental imagery” and “mental practice”, were also used due to the absence of specific
MeSH descriptors. The detailed search strategy for PubMed database is shown in Supple-
mentary Materials (Table S1). No filters related to the date of publication were used. The
results were filtered to obtain studies published in English, Spanish and French languages.
Search strategies in the different databases are shown in Table 1.
Table 1. Search strategy for the different databases.
Databases Search
Medline/PubMed, Scopus, CINAHL,
Cochrane, Web of Science
(“motor imagery” OR “mental imagery” OR
“mental practice”) AND “multiple sclerosis”
AND rehabilitation
PEDro Motor imagery in multiple sclerosis
2.2. Eligibility Criteria
The articles were selected based on the research question, elaborated following the
PICOS model [25]: (1) Population: adults pwMS, (2) Intervention: interventions using
MI isolated (non-combined) involving any internal/external stimulus, such as auditory
guides, visual guides, among others; (3) Comparison: conventional physical therapy, no
intervention, and other therapies; (4) Outcomes: motor improvements, QOL and fatigue;
and (5) Study type: clinical trials (controlled and non-controlled, randomised and non-
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randomised) and pilot studies. Only the results related to pwMS were considered when
the studies included data about other neurological pathologies.
2.3. Assessment of the Methodological Quality and Risk of Bias
The Checklist for Measuring Study Quality [26] was used to analyse the methodologi-
cal quality of the included studies. This tool uses 27 questions (“yes”, “no” or “unable to
determine”) through five different sections related to the overall quality of the study, the
ability to generalise findings of the study, the assessment of the bias in the intervention
and outcome measure(s), the assessment of the bias from sampling or group assignment,
and the possibility that findings are due to chance.
The assessment of the risk of bias was performed through The Cochrane Collabora-
tion’s tool [27], using the Review Manager 5.4 software (the Cochrane Collaboration, The
Nordic Cochrane Centre, Copenhagen, Denmark). This tool allows the evaluation and
rating of the risk of bias in terms of “low risk”, “high risk” and “unclear risk”.
2.4. Selection Process and Data Extraction
The search was conducted using the different keywords previously described in the
different scientific databases. After reading in detail the title and abstract, according
to the previous criteria, potentially relevant articles were identified, and the duplicated
documents were excluded. Finally, an exhaustive verification of the inclusion criteria
applied to the articles included in this systematic review was carried out.
Two independent reviewers (A.G.-B.-B.-Z. and C.L.-M.) were actively involved in
study selection, review, and systematic data extraction from each included study. An
additional reviewer (D.L.-A.) took part in the consensus of the different decisions. The
following information was extracted from each article: author, year of publication, de-
mographic characteristics of the participants (total number of participants, number of
participants in both groups, average age), as well as the functional stage of participants,
and characteristics of the intervention carried out (the type of MI, intensity and timing of
the sessions, measurement instruments, and results).
3. Results
From a total of 70 studies initially identified, only five were considered for a qualitative
synthesis (Figure 1). A list of the excluded articles and reasons, is shown in Supplementary
Materials (List S1).
3.1. Methodological Quality and Risk of Bias
The mean methodological quality score was 17.4 points, with 12 [28] and 21 [21] points
as the minimum and maximum obtained, respectively. Table 2 shows the results of the
methodological quality of the included studies. Regarding the risk of bias of the studies,
the two studies of Seebacher et al. [20,29] reached the highest risk of bias. Conversely,
the study conducted by Kahraman et al. [21] presented the lowest risk of bias. Besides,
in terms of the risk of bias among the studies, the lowest biases were obtained in the
random sequence generation (selection bias), allocation concealment (selection bias) and
the selective reporting (reporting bias). The highest value was found in the blinding of
participants and personnel (performance bias). The results are shown in Figures 2 and 3.
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1. Study quality
Hypothesis/aim 1 1 1 1 1
Outcomes 1 1 1 1 1
Eligibility criteria 1 1 1 1 1
Interventions 1 1 1 1 1
Confounders 0 0 0 0 0
Findings 1 1 1 1 1
Random
variability 1 1 1 1 1
Adverse events 1 0 0 1 1
Lost to follow-up 1 1 1 1 1
Probability values 1 1 1 1 1
2. External validity (study bias)
Source population 0 0 0 0 0
Illustrative sample 0 0 0 0 0
Illustrative treat 1 0 0 0 0
3. Internal validity (study bias)
Blinding of
subjects 1 0 0 0 0
Blinding 1 1 1 1 0
“Data dredging” 1 1 1 1 1
Follow-up adjusts 1 1 1 1 1
Statistical tests 1 1 1 1 1
Compliance 1 1 1 0 1
Outcomes 1 1 1 0 1









et al. 2010 [30]
Bovend’Eerdt
et al. 2009 [28]
4. Internal validity (confounding and selection bias)
Source of patients 1 0 1 0 0
Recruitment
period 1 1 1 1 1
Randomization 1 1 1 0 0
Concealment 0 1 1 0 0
Analysis 0 0 0 0 0
Loss to follow-up 1 0 0 0 0
5. Power
Effect 1 0 0 1 0
TOTAL SCORE 21 19 19 14 12
PORCENTAGE (%)
* 61 59 59 42 38
* Percentage of the maximum score (32 points).
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3.3. Participant Characteristics
A total of 198 pwMS were studied. All samples were exclusively from pwMS except
the articles published by Bovend’Eerdt et al. (2009) [28] and Bovend’Eerdt et al. (2010) [30],
which included several types of patients with neurological pathologies, but only pwMS
were considered. The average age of the individuals studied was between 35 and 52 years.
Studies exclusively analysing pwMS did not exceed 3 points in the expanded disability
status scale (EDSS) [31], ranging from 2 to 2.6 (mild disability in one function or very small
disability in two functions). The EDSS is used to measure the degree of disability in pwMS
and represents the most widely used tool to measure disease outcomes in clinical trials. It
is a feasible scale for assessing the effectiveness of clinical interventions and to monitor
disease progression [31].
The last two studies [28,30], which include other types of neurological patients, did
not show EDSS scores, and only one [30] referred to a low degree of disability as a criterion
for inclusion in the study.
The time since diagnosis in most studies varied from 4 to 19.7 years. When the
chronicity of the pathology was not indicated, it was reported that at least over three
months had elapsed since study participants had their last outbreak.
Int. J. Environ. Res. Public Health 2021, 18, 498 7 of 15
Table 3. Synthesis of Results.
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(ABC) Activities-specific Balance Confidence; (ARAT) Action Research Arm Test; (BI) Barthel Index; (C) Control: no intervention; (DGI) Dynamic Gait Index; (EDSS) Expanded Disability Status Scale; (EG)
Electrogoniometer; (EQ-5D-3L) Euroquol-5D-3L Questionnaire; (GAS) Goal Attainment scale; (LOS) Limits of Stability; (MAS) Modified Ashworth Scale; (MFIS) Modified fatigue impact scale; (MI) Motor
imagery; (MIG) Motor Imagery Group; (MING) Motor imagery no guided; (MMI) Music motor imagery; (MS) Multiple Sclerosis; (MSIS-29) Multiple Sclerosis Impact Scale-29; (MSWS-12) 12-Item Multiple
Sclerosis Walking Scale; (MTVMI) Metronome verbally motor imagery; (MusiQoL) Multiple Sclerosis International Quality of Life questionnaire; (MVMI) Music verbally motor imagery; (N) Total number of
patients; (NEADL) Nottingham Extended Activities of Daily Living; (PASAT) Paced Auditory Serial Addition Test; ((PETTLEP) Physical, Environment, Task, Timing, Learning, Emotion, Perspective model;
(PMR) Progressive muscle relaxation; (PST) Postural Stability Test; (RMI) Rivermead Mobility Index; (SF-36) Short Form-36 Health Survey; (TUG) Timed Up and Go; (TRBMI) Telerehabilitation-bases motor
imagery; (T25FW) Timed 25-Foot Walk; (2MWT) 2-Minute Walk Test.
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3.4. Intervention Characteristics
All studies used guided (involving any internal/external stimulus to provide feedback)
MI, except Kahraman et al. [21] and Bovend’Eerdt et al. (2009) [26]. The most common
guide was verbal, sometimes combined with music and a metronome. Furthermore,
Holmes and Collins [32] used the physical, environment, task, timing, learning, emotion,
perspective model (PETTLEP) approach. The PETTLEP model was developed to aid sports
psychologists in designing and delivering MI interventions for athletes, and its application
has been recommended for neurological patients [33].
The intervention duration was very heterogeneous, ranging from 17 to 30 min, the
total number of sessions varied from 10 to 56, and the sessions per week from 4 to 8.
3.5. Outcomes Measures
Each of the variables is detailed below with the measurement instruments used for
their evaluation.
3.5.1. Gait
Four articles [20,21,29,30] proposed the use of MI to improve walking parameters in
pwMS. These parameters were walking speed and distance, functionality and perceived
walking ability. Despite the heterogeneity of the samples and methodologies, the majority
of them showed significant improvements with the application in the MI intervention
group compared to non-intervention.
The most studied parameter was walking speed, and the most used outcome mea-
sure to evaluate was Timed 25-Foot Walk (T25FW) used by three studies [20,21,29]; this
test shows obvious real-world relevance, and has been strongly correlated with other
measures of walking and lower limb function in pwMS [34]; The 6-Minute Walk Test
(6MWT) was measured by two studies [20,29] and the 2-Minute Walk Test (2MWT) by
Kahraman et al. [21]. Despite not being valid to determine aerobic capacity in PwMS, the
validation of the 2MWT with other functional measures (like the TUG) has been demon-
strated in pwMS; this test provides an efficient and practical alternative to the 6MWT [35].
In the case where different MI interventions were compared, verbally guided MI obtained
the best results, as reported by Seebacher et al. [20]. Other variables, such as dynamic
balance during walking and perceived walking ability were also significantly improved in
the MI group in the study by Kahraman et al. [21].
Other gait parameters related to functionality were evaluated using the Rivermead
Mobility Index (RMI) and Timed Up and Go (TUG) by the Bovend’Eerdt studies [28,30].
These results were less extrapolated since the number of pwMS was especially small. Kahra-
man et al. [21] used the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) to measure the
subjective impact of the disease on gait performance in these patients, obtaining significant
improvements in the MI group.
3.5.2. Balance
This variable was measured in the study by Kahraman et al. [21] using the limits
of stability measurement and three tests: Activities-specific Balance Confidence (ABC),
Postural Stability Test (PST) and the dynamic balance during gait through the Dynamic
Gait Index (DGI). They found significant improvements after the use of MI, both in static
and dynamic balance, as well as during the performance of fundamental tasks in their
daily lives.
3.5.3. Fatigue
The most often used scale to measure fatigue was the Modified Fatigue Impact Scale
(MFIS), a specific fatigue scale in pwMS, which was used in three studies [20,21,29]. All the
studies showed significant improvements in the MFIS using MI. Specifically, there were
higher differences in the items referring to physical fatigue, followed by cognitive fatigue
in the study by Seebacher et al. (2019) [20], compared to the other studies. Seebacher et al.
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(2017) [30] only obtained significant improvements on fatigue in the group receiving verbal
guides and the metronome, compared to the musical guide and the control groups.
3.5.4. Quality of Life
Three studies [20,21,29] measured QOL, and all the studies obtained significant results
in favour of MI. The most used QOL scale was the Multiple Sclerosis Impact Scale-29
(MSIS-29), and it was used by the two studies of Seebacher et al. [20,29]. Another specific
scale for pwMS was the Multiple Sclerosis International Quality of Life questionnaire
(MUSI-QOL), as used by Kahraman et al. [21]. Other generic QOL scales that were used




Bovend’Eerdt et al. (2010) [30] used the Action Research Arm Test (ARAT) to measure
the upper limb function. This scale evaluates the ability to handle and transport smaller and
larger objects and is recommended as a quantification of arm function in pwMS, although
it suffers from poor sensitivity to mild impairment [36]. No significant improvements were
obtained after the intervention.
Muscular Tone and Range of Movement
Bovend’Eerdt et al. (2009) [28] used The Modified Ashworth Scale (MAS) and the
ElectroGoniometer to measure the muscle response during passive stretching and range of
movement. MAS scale is the most commonly used scale for assessing the degree of spastic-
ity; however, the validity, reliability and sensitivity of this scale have been challenged [37].
The use of the ElectroGoniometer allows the evaluation of how this affects the range of
movement. The results of this study showed no significant differences in EG and MAS
measurements between the muscle relaxation and MI group.
Functional Independence
The two studies published by Bovend’Eerdt et al. [28,30] measured the impact of
MI on functional independence. Bovend’Eerdt et al. (2010) [30] measured the functional
impact of MI treatment on activities of daily living through the Nottingham Extended
Activities of Daily Living (NEADL) scale and the Goal Attainment Scale (GAS). The NEADL
seems to be appropriate for the assessment of disability in pwMS, but the range of items
needs to be extended. The Goal Attainment Scale (GAS) is an individualised outcome
measure, including goal selection and goal scaling, in order to calculate the patient goals
achievement. Only significant post-intervention improvements in GAS were observed.
Bovend’Eerdt et al. (2009) [28] used the Barthel Index (BI), which is a commonly used
scale measuring functional independence, and it has been validated for pwMS [38]. No
significant improvements were obtained after the intervention.
4. Discussion
The results of the present study focused on the main aspects of the MI technique
for interventions on pwMS, its applicability, and the key features to be considered for
implementing future trial protocols. One main aspect is the type of MI used, as it can
be implemented with metronome, verbal, musical guides or following the PETTLEP [32]
model. In this respect, the main interest of the PETTLEP model is on the influence of
domains, such as the emotional one, on motor functioning. Most studies [20,21,29] used
external guides in their protocols. In line with other authors [39], it has been shown that
there are more relevant improvements with the use of these kinds of guides. Results
showed that pwMS could better imagine movements when they are provided with external
signals during MI intervention. In particular, Kharaman et al.’s [21] results support this,
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especially underscoring the positive effects of MI on balance, walking speed, fatigue and
QOL.
The degree of disability, the chronicity of the disease and the age of the subjects
also influence the performance of the technique. Cognitive and motor dysfunction may
be associated with impaired motor imaging capabilities, which raises questions about
the applicability and efficacy of this technique in neurological diseases and in pwMS. In
this line, Heremans et al. [40] explained how cognitive dysfunction in pwMS affects the
accuracy and duration of MI. In the same way, Tabrizi et al. [41] examined MI capabilities
in pwMS with low scores on the EDSS and proved that there are significant differences
compared to healthy controls. McInnes et al. [42] concluded that subjects with damage
to specific brain structures, including the parietal and frontal lobes, show impaired MI
ability. Mulder et al. [43] investigated the ability of different age groups for MI and found
that elderly patients need an adaptation of the technique to their cognitive abilities. In
particular, many of the subjects showed significant differences between first-person and
third-person MI representations, with the former raising greater difficulties. Therefore,
decisions about the use of MI in neurorehabilitation should be based, in part, on the specific
functional profile of the patient’s underlying pathophysiology.
Regarding the intensity of the therapy, while Seebacher et al. [20,29] used a more
intense strategy in terms of the number of sessions and weeks of application, Kahra-
man et al. [21] reduced the intensity to 16 sessions an extended it for 8 weeks. Both studies
showed the positive effects of MI, so it can be concluded that it is possible to reduce the
number of MI sessions due to the influence of time on better processing of the MI-related
changes.
Telerehabilitation based on an MI [21] programme was introduced in 2019 as an
innovative intervention applied to pwMS. Its results were favourable in improving motor
and cognitive functions. Therefore, this study suggested that telerehabilitation combined
with MI seemed feasible and applicable in pwMS, although the intervention should be
individualised for each patient and situation by the therapist.
Despite the lack of studies, partly due to the novelty of the technique in neuroreha-
bilitation of pwMS, and due to the methodological differences between the few studies, it
is difficult to obtain definitive conclusions on the effectiveness of MI in pwMS. However,
considering the present systematic review results, qualitative analysis can be envisaged to
deepen the different aspects of the considered variables, the technique and the application
of MI in pwMS, which could guide future clinical trial protocols.
4.1. Gait
In addition to the positive results through the use of generic MI shown, the studies
distinguished among the different types of MI application (music guided, music + verbal
guidance, unguided or with the application of the PETTLEP model). Kahraman et al. [21]
obtained less difference after the intervention, showing 0.33 s compared to the 0.8/0.9 s
average of the studies by Seebacher et al. [20,29]. This discrepancy can be explained
because patients with greater walking impairment showed a greater response to treatment
or to the use of combined musical and verbal guides. Kahraman et al. [21] did not find
alterations in the improvement of the 2-min walking test (2MWT) [35], in contrast with
Seebacher et al. [20,29], who used the 6-min walking tests (6MWT). Although the results
of these tests can be comparable [44], only the Seebacher et al. [20,29] findings could
be considered as clinically significant [45]. Since rhythm-based music interventions can
improve the gait parameters of velocity and cadence in pwMS [46], the results suggest
that the combination of verbal and musical-guided MI should be used to improve the
spatiotemporal parameters of gait.
4.2. Balance
Kahraman et al. [21] reported the static and dynamic balance variables using MI,
showing significant differences in improving balance in pwMS. According to the litera-
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ture [47,48], 50–60% of pwMS experienced falls during walking due to a loss of dynamic
balance and differences in the biomechanical pattern [49]. The measurement of this variable
using MI is clinically interesting, given its functional impact on pwMS. The instrumen-
talised evaluation of this variable in future studies will support the findings [50]. In the
case of pwMS, visual disturbances can greatly influence balance. Although there is still no
solid evidence on the supremacy of some sensory cues over others [51], it seems that visual
cues are more important than auditory cues in balance in these patients [52]. However,
these results suggest that the non-use of visual guidance, as in the case of the MI, did not
prevent optimal results in improving balance through their use. The telerehabilitation
modality used did not seem to affect the results either.
4.3. Fatigue
The significant results obtained in terms of fatigue, one of the most prevalent symp-
toms in pwMS, are encouraging. Cognitive mechanisms seem directly to interfere with
fatigue, and the use of the MFIS is relevant because it takes into account both mental
and physical fatigue [53,54], especially in a technique in which the cognitive demand
may be greater than other physiotherapeutic techniques. Therefore, the duration of the
sessions is also a factor to consider when carrying out an MI intervention due to the mental
fatigue that pwMS often experience. Mental fatigue appears as an explanatory variable
for cognitive performance and specifically in tasks that require speed of processing and
executive control [55]. The length of the session in the studies included in this systematic
review vary from 30 min [21] to 17 min [20,29], and all the protocol used contributed to the
improvement of both mental and physical fatigue.
4.4. Quality of Life
The QOL is an important variable to take into account in physical therapy inter-
ventions and is key in the choice of techniques. Together with the scientific evidence
of improvement in other functional variables, the results are very positive in terms of
improvement in this area. It is recommended to include this in any future research in this
field. Due to the deficits in motor control that pwMS present and which negatively affect
QOL, the development of easy and convenient rehabilitation techniques is crucial in the
clinical setting. Therefore, MI is a promising, cost-effective, and non-invasive complement
to conventional therapy, which reduces deterioration and improves certain functional
outcomes, with the possibility of carrying out this task at home [13,20].
4.5. Upper Limb Function
No significant improvements were obtained after intervention in the study of Bovend’Eerdt
et al. [30], although the authors stated that the small sample size and intervention dose used
could have affected the results. Furthermore, according to the authors, more support and
training should be received by the therapists and patients in order to achieve the motor recovery
of pwMS using the MI technique. Since the relationship between the upper and lower limb
impairments in pwMS was only moderate [56], the implementation of studies analysing the
effects of MI-based interventions that focus on the upper limb, such as the one described, are
recommended in order to obtain a global overview of the overall motor function in pwMS.
4.6. Muscular Tone and Range of Movement
It should be considered that the sample size of the study of Bovend’Eerdt et al.
(2009) [28] was the smallest (only a small number of the total were pwMS) and the protocol
of action was not homogeneous, varying from 8 to 56 sessions and applied by caregivers or
physical therapists. However, the authors commented that in the MI group, the feelings
of discomfort during stretching were much lower, which is a positive aspect in clinical
practice with patients with shortening and spasticity. With this regard, a measurement is
needed that takes into account spasticity globally to make well-founded conclusions [57]
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and establish correlations between improvements in spasticity and its impact on balance
and gait.
4.7. Functional Independence
Despite the non-significant results, which may be related to the aforementioned
factors in the previous section, the authors used different scales that could help to establish
a complete diagnosis through the Functional Classification of Independence [58]. It is
essential to establish this diagnosis to develop objectives that allow the programming of
interventions aimed at improving the activities of daily living of patients.
4.8. Study Limitations
Some limitations were found in this systematic review. One limitation was related to
the use of strict inclusion criteria (only isolated MI interventions were included). Another
limitation was the inclusion of studies analysing patients with different neurological
disorders, the heterogeneity of the MI intervention protocols used by the studies, and
the differences in disability levels. Future research should be based on controlled and
randomised clinical trials, with patients exclusively with multiple sclerosis, with a proper
and specific methodology that reinforce the use of MI for the improvement of variables as
gait, fatigue, balance, and QOL. Furthermore, it would be appropriate to further investigate
whether MI as a complementary treatment to conventional therapy would be beneficial to
apply at the beginning of sessions, at the end of sessions or in stand-alone sessions.
5. Conclusions
Although the evidence is limited, the use of MI through the combination of musical
and verbal guides, compared to non-intervention or other interventions, can produce
positive effects on walking speed and distance, fatigue and QOL in pwMS who have low
EDSS scores. In addition, MI obtained significant improvements in dynamic balance and
perceived walking ability. However, these results should be taken with caution because of
the limited number and heterogeneity of the studies analysed.
Preliminary results suggested that interventions using the MI technique, applied with
a minimum of 16 sessions, can be effective in the functional recovery of these patients.
Nevertheless, due to the limited number of studies analysed, the results must be taken
with caution.
Despite the development of MI in the neurorehabilitation of patients with stroke and
Parkinson’s disease being higher, it is necessary to continue researching on pwMS. The
results obtained seem to be promising, but there are limitations when the technique is
applied in the presence of cognitive impairments, being easier to use in patients with low
EDSS scores. In this way, we encourage authors to use large sample sizes to analyse the
effects of MI interventions on different clusters based on EDSS, with specific interventions
for both upper and lower limbs.
In conclusion, the number of clinical trials with high methodological quality using
MI-based interventions for motor recovery of pwMS is low. Future research needs to be
based on randomised controlled trials with homogeneous intervention programmes and
disability levels, employing measuring instruments assessing pain, spasticity, risk of falls,
QOL and functional scales. These improvements will allow obtaining more conclusive
findings of the real impact of the technique on pwMS lives.
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